Jb Capital LLC Eli Lilly & CO Transaction History

Jb Capital LLC

$1.71 Billion
Q3 2024

A detailed history of Jb Capital LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Jb Capital LLC holds 1,137 shares of LLY stock, worth $850,487. This represents 0.06% of its overall portfolio holdings.

Number of Shares

1,137

Previous 1,004 13.25%

Holding current value

$850,487

Previous $909,000 10.78%

% of portfolio

0.06%

Previous 0.06%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 31, 2024	BUY	$772.14 - $960.02 $102,694 - $127,682	133 Added 13.25%	1,137 $1.01 Million
Q2 2024 Jul 24, 2024	SELL	$724.87 - $909.04 $2.08 Million - $2.61 Million	-2,866 Reduced 74.06%	1,004 $909,000
Q1 2024 Apr 30, 2024	BUY	$592.2 - $792.28 $1.72 Million - $2.3 Million	2,904 Added 300.62%	3,870 $3.01 Million
Q4 2023 Jan 22, 2024	BUY	$525.19 - $619.13 $16,280 - $19,193	31 Added 3.32%	966 $563,000
Q3 2023 Oct 25, 2023	BUY	$434.7 - $599.3 $46,078 - $63,525	106 Added 12.79%	935 $502,000
Q2 2023 Jul 25, 2023	BUY	$350.74 - $468.98 $20,693 - $27,669	59 Added 7.66%	829 $388,000
Q1 2023 Apr 25, 2023	BUY	$310.63 - $364.82 $21,433 - $25,172	69 Added 9.84%	770 $264,000
Q4 2022 Jan 23, 2023	SELL	$321.55 - $374.67 $3,858 - $4,496	-12 Reduced 1.68%	701 $0
Q3 2022 Oct 14, 2022	SELL	$296.48 - $337.87 $200,716 - $228,737	-677 Reduced 48.71%	713 $231,000
Q2 2022 Jul 28, 2022	BUY	$278.73 - $327.27 $146,611 - $172,144	526 Added 60.88%	1,390 $451,000
Q1 2022 Apr 19, 2022	SELL	$234.69 - $291.66 $76,743 - $95,372	-327 Reduced 27.46%	864 $248,000
Q4 2021 Feb 02, 2022	BUY	$224.85 - $279.04 $41,822 - $51,901	186 Added 18.51%	1,191 $328,000
Q3 2021 Dec 08, 2021	BUY	$221.6 - $272.71 $222,708 - $274,073	1,005 New	1,005 $232,000

Others Institutions Holding LLY

# of Institutions

4,004

Shares Held

752M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $711B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jb Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jb Capital LLC with notifications on news.

Account